Clinical trial
Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Clemizole HCl as Adjunctive Therapy in Patients With Lennox-Gastaut Syndrome
NCT05066217 is registered in ClinicalTrials.gov with Epygenix as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Clemizole HCl as Adjunctive Therapy in Patients With Lennox-Gastaut Syndrome
- Lead sponsor
- Epygenix
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- April 9, 2025
- Completion date
- November 1, 2029
- Enrollment
- 260 (estimated)
- Sites
- 71
Conditions
As the registry lists them; a condition with its own page is linked.